Ashley Hall - Oct 11, 2020 Form 3 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Chief Development Officer
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Oct 11, 2020
Transactions value $
$0
Form type
3
Date filed
10/14/2021, 04:39 PM
Next filing
Nov 15, 2021

No securities are beneficially owned.